retatrutide purchase online Buy Reta (Retatrutide) Research Peptide Australia Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

A competing pill from Eli Lilly is also expected to receive FDA approval in the coming months, setting the stage for a brand-new era of GLP-1 competition

WorldatWork & IFEBP, 2024) The Data Explained: GLP-1 Coverage Adoption Coverage for GLP-1s among large employers (500+ employees) grew from 41% in 2023 to 44% in 2024, with projections showing continued expansion as employers weigh cost versus employee demand (Intercept Health, HR Dive)

Obesity also raises the risk of several cancers including colorectal, liver, kidney, pancreatic, endometrial, ovarian, and post-menopausal breast cancers

Glp-1 Diet Plan Starting at $55/week Plans available of 4, 8 or 12 weeks Choose the plan that best suits you and then select your bundle

The company announced earlier on Monday that it plans to launch 10 different phase 3 studies of obesity compounds from Metsera by the end of the year, including one it launched in November